Diansong Zhou

26PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingPharmacogenomicsStatistical and quantitative geneticsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 14, 2026
Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

|Aug 12, 2026
PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD).

|Apr 14, 2026
Is a Clinical Trial With a Non-Bioequivalent Batch Necessary? The Critical Role of Intrasubject Variability in Olaparib Formulation Bridging by PBPK.

Jin Dong, Andrea Moir, Xavier Pepin

|Feb 15, 2026
Optimal Dosage Justification for Datopotamab Deruxtecan in HR-Positive/HER2-Negative Breast Cancer Through Model-Informed Drug Development Approaches.

Zoey Tang, KyoungSoo Lim, Yu Jiang

|Feb 04, 2026
Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling.

Marija Kekic, Oleg Stepanov, Wenjuan Wang

|Nov 12, 2025
Population pharmacokinetics and exposure-response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study.

Xiaoying Zhao, Junjie Ding, Jiajia Zhao

Pageof 5

Frequent Collaborators

5 joint publications

Weifeng Tang

4 joint publications

Jin Dong

3 joint publications

Sharma Pradeep

2 joint publications

Marie Cullberg